Transcriptional regulation of α1-adrenoceptor gene in the rat liver during different phases of sepsis  by Dong, Lin-Wang et al.
Transcriptional regulation of K1-adrenoceptor gene in the rat liver during
di¡erent phases of sepsis
Lin-Wang Dong, Jun Yang, Li-Jia Tong, Chaoshu Tang, Maw-Shung Liu *
Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, 1402 S. Grand Blvd.,
St. Louis, MO 63104-1028, USA
Received 17 August 1998; received in revised form 28 October 1998; accepted 28 October 1998
Abstract
Changes in K1-adrenoceptor (K1AR) gene expression in the rat liver during different phases of sepsis were studied. Sepsis
was induced by cecal ligation and puncture (CLP). Septic rats exhibit two metabolically distinct phases: an initial
hyperglycemic phase (9 h after CLP, early sepsis) followed by a hypoglycemic phase (18 h after CLP; late sepsis). The
[3H]prazosin binding studies show that the density of K1AR was increased by 30% during the early phase while it was
decreased by 24% during the late phase of sepsis. Western blot analyses reveal that K1AR protein level was elevated by 48%
during early sepsis but was decreased by 55% during late sepsis. Northern blot analyses depict that the steady-state level of
K1bAR mRNA was enhanced by 21% during the early phase but was declined by 29% during the late phase of sepsis. Nuclear
run-off assays show that the transcription rate of K1bAR gene transcript was increased by 76% during early sepsis while it was
decreased by 29% during late sepsis. The actinomycin D pulse-chase studies indicate that the half-life of K1bAR mRNA
remained unaffected during the early and the late phases of sepsis. These findings demonstrate that during the early phase of
sepsis, the increase in the rate of transcription of K1bAR gene paralleled with the elevations in the K1bAR mRNA abundance
and K1AR protein level, while during the late phase of sepsis, the decrease in the rate of transcription of K1bAR gene
coincided with the declines in the K1bAR mRNA abundance and the K1AR protein level in the rat liver. These observations
indicate that the altered expression of K1AR genes in the rat liver during the progression of sepsis was regulated
transcriptionally. ß 1999 Elsevier Science B.V. All rights reserved.
Keywords: Septic shock; Glucose dyshomeostasis ; Hepatic dysfunction; Gene expression
1. Introduction
Sepsis, septic shock, and ensuing multiple organ
system failure continue to be the most common
causes of death in surgical intensive care units, de-
spite various major advances in the treatment of sep-
sis [1,2]. A disturbance in glucose homeostasis has
been recognized as one of the major metabolic alter-
ations during sepsis. This disturbance is character-
ized by a rapid depletion of liver glycogen content,
an impaired glycogenesis, an accelerated glycogenol-
ysis, and a depressed gluconeogenesis. The ultimate
result of these metabolic alterations is the develop-
ment of an initial hyperglycemia followed by a pro-
gressive hypoglycemia [1^3]. The mechanisms re-
sponsible for the altered glucose homeostasis during
the progression of sepsis remain unclear. Metabolic
pathways such as glycogenesis and gluconeogenesis
in the liver are known to be regulated by catechol-
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amines through the Ca2-linked K-adrenoceptor
(KAR) and the cAMP-linked L-adrenoceptor (LAR)
mediation [4,5]. KAR consists of two di¡erent major
subtypes, K1, and K2, with K1AR being the predom-
inant subtype (75^80%) expressed in the rat liver
[5,6]. Catecholamine-stimulated glycogenolysis in
the rat liver occurs primarily via K1AR mediation
[5,6] and the activation of K1AR results in an in-
crease in hepatic glucose output into the circulation
[6,7]. Previous work from our laboratory has indi-
cated that during the early stage of sepsis, K1AR
was overexpressed in the rat liver and that the over-
expression of K1AR was correlated with the develop-
ment of hyperglycemia, while during the late stage of
sepsis, K1AR was underexpressed and that the under-
expression of K1AR was associated with the forma-
tion of hypoglycemia [8]. It is of interest to note that
a similar biphasic alteration in the density of K1AR
was also observed in human livers with intraabdomi-
nal sepsis [9]. Since hepatic K1AR responsiveness has
been reported to be regulated through alterations via
K1AR gene expression under a variety of conditions
[10^12], the present study was undertaken to examine
whether the altered expression of K1AR is regulated
through alterations in its gene transcript in the rat
liver during the two di¡erent glycemic phases of sep-
sis.
2. Materials and methods
2.1. Materials
[7-methoxy-3H]Prazosin (85 Ci/mmol) was pur-
chased from DuPont-New England Nuclear (Boston,
MA). [K-32P]dCTP (3000 Ci/mmol) and [K-32P]UTP
(3000 Ci/mmol) were purchased from ICN Pharma-
ceuticals (Costa Mesa, CA). Prazosin, Tris and SDS
were products of Sigma (St. Louis, MO). Actinomy-
cin D, proteinase K, ribonuclease A, deoxyribonu-
clease I and EcoRI were supplied by Promega (Mad-
ison, WI). Full-length hamster K1bAR cDNA cloned
into the EcoRI site of plasmid pSP65 (the insert was
2 kb) [13] was a generous gift of Dr. Marc G. Caron,
Howard Hughes Medical Institute, Duke University
Medical Center. 28S rRNA oligonucleotide (40 mer)
was obtained from Calbiochem-Novabiochem Inter-
national (San Diego, CA). Polyclonal (rabbit) anti-
K1AR antibody was obtained from A⁄nity Biore-
agents (Golden, CO). Anti-rabbit IgG, horseradish
peroxidase-linked species-speci¢c whole antibody,
ECL Western blotting detection reagent, and Hyper-
¢lm-ECL were products of Amersham Life Science
(Arlington Heights, IL). Other chemicals and re-
agents were of analytical grade.
2.2. Animal model
All animal experiments in this study were per-
formed with the approval of the Animal Care Com-
mittee of Saint Louis University School of Medicine,
and in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory
Animals. Male Sprague-Dawley rats weighing from
270 to 320 g were used. All animals were fasted over-
night with free access to water. They were divided
into three groups: control, early sepsis, and late sep-
sis. Sepsis was induced by cecal ligation and puncture
(CLP) as described by Wichterman et al. [14] with
minor modi¢cation. Under halothane anesthesia, a
laparotomy was performed (the size of the incision
was 2.5 cm), and the cecum was ligated with a 3-0
silk ligature and punctured twice with an 18-gauge
needle. The cecum was then returned to the perito-
neal cavity and the abdomen was closed in two
layers. Control rats were sham-operated (a laparot-
omy was performed and the cecum was manipulated
but neither ligated nor punctured). All animals were
resuscitated with 4 ml/100 g body weight of normal
saline at the completion of surgery and also at 7 h
post surgery. Animals were fasted but had free access
to water after operative procedures. After anesthetiz-
ing the animals with 2% chloralose in 20% urethane
(5 ml/kg, i.p.), livers were removed 9 or 18 h post
operation and were then used for the biochemical
and molecular biological studies. Early and late sep-
sis refers to those animals sacri¢ced at 9 and 18 h,
respectively, after CLP. The mortality rates were 0%
(0/24) for control, 11% (3/27) for early sepsis, and
20% (6/30) for late sepsis. Previous experiments in-
dicate that in septic rats, plasma glucose concentra-
tion was elevated by 20% (P6 0.01) during the early
phase while it was decreased by 69% (P6 0.01) dur-
ing the late phase of sepsis [8].
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2.3. [3H]Prazosin binding to liver plasma membranes
K1AR binding assay was carried out using
[3H]prazosin as a radioligand according to a proce-
dure previously described by us [8,15]. Liver plasma
membranes were prepared by sucrose gradient cen-
trifugation as described previously [8]. The standard
assay mixture in a ¢nal volume of 0.2 ml contained
10 mM MgCl2, 50 mM Tris-HCl (pH 7.4), 1 nM
[3H]prazosin with a radioactivity of approx. 10 000
cpm, and 0 or 2.5 WM unlabeled prazosin. The mix-
ture was preincubated at 37‡C for 2 min. The bind-
ing assay was subsequently initiated by the addition
of plasma membranes containing 50 Wg protein and
was allowed to proceed for 20 min at 37‡C. At the
end of each incubation, the reaction mixture was
diluted with 5 ml of ice-cold washing solution (10
mM MgCl2 and 50 mM Tris-HCl, pH 7.4) and ¢l-
tered immediately through a 0.45 Wm glass ¢ber ¢lter
paper (Baxter Healthcare) under suction. The ¢lter
paper was washed three times with 5 ml washing
solution. The ¢lter paper was then dried and the
radioactivity was determined with a liquid scintilla-
tion counter. The speci¢c binding was de¢ned as the
bound radioactivity displaceable by 2.5 WM of unla-
beled prazosin.
2.4. Determination of K1AR protein level by Western
blot analysis
Western blot analysis was performed according to
the method of Gallagher et al. [16] with minor mod-
i¢cation [17]. Samples of liver plasma membranes
containing 90 Wg protein were denatured and sub-
jected to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) (7^10% polyacrylamide
gradient gel). Using Bio-Rad Trans-Blot cell, pro-
teins separated by SDS-PAGE were transferred to
a polyvinylidene £uoride membrane (Bio-Rad) at
8 mA (constant current) for 14^16 h in transfer bu¡er
(25 mM Tris base, pH 8.3, 192 mM glycine, 5% (v/v)
methanol). Non-speci¢c binding sites were blocked
with 10% (w/v) of non-fat dry milk in Tris-bu¡ered
saline (TBS, 20 mM Tris-HCl, pH 7.4, 137 mM
NaCl) for 4 h at 4‡C. Blots were washed three times
(10 min each) with TBST (TBS containing 0.5%
Tween-20) followed by incubation with a 1/400 dilu-
tion of a polyclonal antibody raised to rabbit K1AR
for 5 h at room temperature. Subsequently, the blots
were washed three times (10 min each) with TBS and
then incubated with a 1/2000 dilution of an anti-rab-
bit IgG, horseradish peroxidase-linked species-specif-
ic whole antibody for 1 h at room temperature. The
blots were then washed four times (10 min each) with
TBST, followed by incubation with enhanced chem-
iluminescent (ECL) Western blotting detection re-
agent, and ¢nally exposed to Hyper¢lm-ECL for
1 h. Autoradiographs were scanned with a Hewlett-
Packard ScanJet 4C Scanner, and the relative den-
sities were quanti¢ed by a Jandel Scienti¢c Software
program (SigmaGel).
2.5. Determination of the steady-state level of K1bAR
mRNA by Northern blot analysis
Northern blot analysis was performed as described
by Sambrook et al. [18] and Rossby and Cornett [12]
with modi¢cation [17]. Total cellular RNA was ex-
tracted from control and septic rat livers with acid
guanidinum thiocyanate-phenol-chloroform mixture
using a RNA isolation kit (bulletin 1, TEL-TEST
‘B’, Friendswood, TX). RNA concentration was de-
termined by absorbance at 260 nm, and the purity
was assayed by the 260/280 nm ratio. Samples con-
taining 30 Wg of total cellular RNA were denatured,
size fractionated on 1% agarose-6.6% formaldehyde
denaturing gels, and then transferred to nylon mem-
branes (Micron Separations, Westborough, MA) in
10USSC (saline-sodium citrate) (1USSC contained
0.15 M NaCl and 15 mM trisodium citrate, pH
7.0) using a standard method [18]. The membranes
were ultraviolet cross-linked, baked at 80‡C for 2 h,
and then prehybridized at 42‡C for 3 h in 50% form-
amide, 5USSC, 5UDenhardt’s solution (1UDen-
hardt’s solution contained 0.02% each of bovine se-
rum albumin (BSA), polyvinylpyrrolidone, and
Ficoll), 0.5% SDS, and 100 Wg/ml of denatured frag-
mented salmon sperm DNA. The prehybridization
solution was replaced with fresh solution containing
radioactive cDNA probe labeled with [K-32P]dCTP
according to the random primed labeling technique
[18] and the mixture was hybridized overnight at
42‡C. The speci¢c cDNA probe used was full-length
hamster K1bAR cDNA cloned into the EcoRI site
(5P...3P orientation) of plasmid pSP65 (the insert
was 2 kb), a generous gift of Dr. Marc G. Caron
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(Howard Hughes Medical Institute, Duke University
Medical Center). Insert-containing plasmids were di-
gested with the appropriate restriction enzyme and
the inserts were puri¢ed by preparative agarose gel
electrophoresis. After hybridization, the membranes
were washed three times (10 min each) in 1USSC-
0.1% SDS at room temperature and four times (20
min each) in 0.1USSC-0.1% SDS at 55‡C. Washed
membranes were exposed to Kodak X-OMAT AR
¢lm at 370‡C with DuPont Cornex Lightening
Plus intensifying screens. Hybridization with 32P-la-
beled 28S rRNA oligonucleotide served as an inter-
nal control. The hybridization signals were quanti¢ed
by densitometric scanning and all K1bAR mRNA
levels were normalized relative to the level of 28S
rRNA.
2.6. Measurement of the transcription rate of K1bAR
mRNA by nuclear run-o¡ assay
Liver nuclei were isolated by the method of Bush
[19]. Liver tissue (approx. 1 g) was homogenized in
10 vols. of a medium containing 2.4 M sucrose, 3.3
mM CaCl2, 2.0 mM MgCl2, 0.1 mM ethylenediam-
inetetraacetic acid (EDTA), 0.1 mM phenylmethylsul-
fonyl £uoride, 5 mM dithiothreitol (DTT), and 10
mM Tris-HCl, pH 7.5. The homogenate was ¢ltered
through four layers of cheesecloth and centrifuged at
40 000Ug for 70 min. The pellet was resuspended in
1 M sucrose containing 1 mM CaCl2, rehomogen-
ized, and then recentrifuged at 2600Ug for 10 min.
The resultant nuclei pellet was resuspended in 40%
glycerol containing 5 mM MgCl2, 0.1 mM EDTA,
5 mM DTT, and 50 mM Tris-HCl, pH 8.0, stored at
370‡C, and then used for nuclear run-o¡ assay. Nu-
clear run-o¡ assay was performed according to the
methods of Greenberg et al. [20] and Deng and Cor-
nett [10] with modi¢cation [17]. The reaction mixture
in a ¢nal volume of 0.5 ml contained 20 mM Tris-
HCl, pH 8.0, 150 mM KCl, 5 mM MgCl2, 2 mM
DTT, 0.5 mM each of ATP, CTP and GTP, and 0.2
WM of [K-32P]UTP containing a radioactivity of 250
WCi. The reaction was initiated by the addition of
2.8U107 nuclei, allowed to proceed for 30 min at
30‡C, and then terminated by the addition of 200
units of deoxyribonuclease I in 300 mM NaCl,
5 mM MgCl2, 10 mM Tris-HCl, pH 7.5, and 1.2
mM CaCl2. Subsequently, 150 Wg of proteinase K
in the presence of 1% SDS and 5 mM EDTA were
added, and the mixture was incubated at 37‡C for 30
min. 32P-Labeled RNA was extracted and puri¢ed as
described by Greenberg et al. [20]. The [32P]RNA
(1.2U107 cpm) was hybridized in 1.4 ml of hybrid-
ization solution (10 mM N-tris(hydroxymethyl)meth-
yl-2-aminoethanesulfonic acid, pH 7.4, 10 mM
EDTA, 0.2% SDS, 300 mM NaCl) with non-labeled
K1bAR cDNA probe (a 2 kb full-length hamster
K1bAR cDNA cloned into the EcoRI site of plasmid
pSP65 obtained from Dr. Marc G. Caron) and syn-
thetic 28S rRNA oligonucleotide, which were immo-
bilized on nitrocellulose membranes. Dot-blot hy-
bridization was carried out at 65‡C for 48 h. After
hybridization the membranes were washed three
times in 1USSC at room temperature, two times in
1USSC at 65‡C for 30 min, and then incubated with
ribonuclease A (10 Wg/ml) at 37‡C for 30 min. The
membranes were washed subsequently in 1USSC-
0.1% SDS at 65‡C for 30 min, rinsed in 1USSC.
Washed membranes were exposed to Kodak X-
OMAT AR ¢lm at 370‡C with intensifying screens
for 7^10 days. Hybridized nuclear [32P]K1bAR and
[32P]28S rRNA transcript abundances were scanned
and quanti¢ed densitometrically. The transcription
rate of K1bAR mRNA was calculated from [32P]RNA
bound to the speci¢c cDNA fragment for K1bAR and
corrected for the amount of input labeled RNA from
28S rRNA oligonucleotide.
2.7. Stability (half-life) assay of liver K1bAR gene
transcript
The stability of liver K1bAR mRNA was measured
by actinomycin D pulse-chase method [21,22] with
modi¢cation [17]. Liver tissue slices (20^30 mg each)
were incubated at 37‡C in Krebs-Henseleit bu¡er
(pH 7.4) containing 2% dialyzed BSA and 5 Wg/ml
of actinomycin D for various time intervals (0, 2, 4
and 6 h). The reaction mixture was constantly equil-
ibrated with a stream of 95% O2-5% CO2. After the
designated time of incubation, total RNA was ex-
tracted from each sample as described earlier for
Northern blot analysis. An aliquot (30 Wg) of ex-
tracted RNA was dot-blotted on a nylon membrane
and hybridized with 32P-labeled cDNA probe (2 kb
full-length hamster K1bAR cDNA cloned into the
EcoRI site of plasmid pSP65) as described for North-
BBADIS 61802 11-2-99
L.-W. Dong et al. / Biochimica et Biophysica Acta 1453 (1999) 207^215210
ern blot analysis. Stringent post-hybridization washes
of the membranes and the detection of the hybridized
signals were performed as described previously. The
half-life of K1bAR mRNA was de¢ned as time re-
quired for the 50% reduction in mRNA level.
2.8. Protein assays and statistical analysis
The protein content of liver plasma membranes
was measured by the method of Lowry et al. [23].
The statistical analysis of the data was performed
using one-way analysis of variance followed by Stu-
dent-Newman-Keuls tests. A P value of less than
0.05 was accepted as statistically signi¢cant.
3. Results
Fig. 1 depicts changes in the density of K1AR in
the rat liver during the early and late phases of sepsis
based on [3H]prazosin binding studies. The maximal
binding capacity (Bmax) for [3H]prazosin binding was
increased by 30% (P6 0.05) during early sepsis but
was decreased by 24% (P6 0.05) during late sepsis
(401 þ 25, 520 þ 60 and 305 þ 20 fmol/mg protein for
control, early sepsis, and late sepsis, respectively).
The a⁄nity (the reciprocal of dissociation constant
(Kd)) for [3H]prazosin binding was not signi¢cantly
a¡ected during sepsis (Kd values in nM: 0.15 þ 0.04,
0.20 þ 0.05, and 0.14 þ 0.02 for control, early sepsis,
and late sepsis, respectively). These data indicate that
the density of K1AR in the rat liver was increased
during the early phase but was decreased during the
late phase of sepsis.
Fig. 2 shows the Western blot analysis of K1AR
protein level in rat liver during di¡erent phases of
sepsis. K1AR protein level was elevated by 48%
(P6 0.01) during early sepsis while it was decreased
by 55% (P6 0.01) during late sepsis (Fig. 2B). These
¢ndings reinforce the data presented in the previous
¢gure that K1AR was overexpressed in the rat liver
during the early phase but it was underexpressed
during the late phase of sepsis.
Fig. 3 shows Northern blot analysis of the steady-
state level of K1bAR mRNA in the control and septic
Fig. 1. Changes in the density of K1-adrenoceptor (K1AR) in
the rat liver during di¡erent phases of sepsis. [3H]Prazosin bind-
ing was performed as described in Section 2. Early sepsis (ES)
and late sepsis (LS) refer to measurements performed at 9 and
18 h, respectively, after cecal ligation and puncture. Vertical
bars indicate standard errors of the mean. Number of experi-
ments is shown in the parentheses within each column.
Fig. 2. (A) A representative autoradiograph of Western blot
analysis. (B) Western blot analysis of K1-adrenoceptor (K1AR)
protein levels in the control and septic rat livers. Western blot
analysis was carried out as described in Section 2 using polyclo-
nal antibodies raised to rabbit K1AR. Vertical bars indicate
standard errors of the mean. Number of experiments is shown
in the parentheses within each column. ES, early sepsis; LS,
late sepsis.
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rat livers. Using total cellular RNA, the speci¢c
K1bAR cDNA probe, and 28S rRNA oligonucleotide
as an internal control to correct for the potential
di¡erence in the amount of RNA loaded, the North-
ern blot analysis reveals two distinct transcripts, an
obvious 3.3 kb species and a weak and barely detect-
able 2.7 kb species. Analyses of the densitometric
signals reveal that the steady-state level of 3.3 kb
K1bAR mRNA was increased by 21% (P6 0.01) dur-
ing early sepsis but was decreased by 29% (P6 0.01)
during late sepsis (Fig. 3B). It should be mentioned
that the yields and the purities of total RNA re-
mained unaltered among control, early septic, and
late septic groups (data not shown), indicating that
changes in the steady-state level of 3.3 kb K1bAR
mRNA were not a result of alterations in the isola-
tion procedure for RNA. These results demonstrate
that K1bAR gene transcript in the rat liver was over-
expressed during early sepsis but it was underex-
pressed during late sepsis.
Figs. 4 and 5 depict changes in the transcription
rate and the stability, respectively, of K1bAR mRNA
in the control and septic rat livers. Nuclear run-o¡
assays reveal that the transcription rate of K1bAR
mRNA was increased by 76% (P6 0.01) during early
sepsis while it was decreased by 29% (P6 0.01) dur-
ing late sepsis (Fig. 4B). It should be mentioned that
the yields (in 107 nuclei/g wet tissue: 9.5 þ 0.5,
10.3 þ 0.5, and 10.5 þ 0.6 for control, early sepsis,
and late sepsis, respectively) and the viabilities (in
%: 96 þ 6, 94 þ 5, and 93 þ 8 for control, early sepsis,
and late sepsis, respectively) of hepatic nuclei isolated
from control, early, and late septic rats were compar-
able, indicating that changes in the transcription
rate of K1bAR mRNA, as shown in Fig. 4B, were
not a result of changes in the isolation procedure
for hepatic nuclei. The actinomycin D pulse-chase
stability assays demonstrate that the half-life of
K1bAR mRNA remained constant during the earlyFig. 3. (A) A representative autoradiograph of Northern blot
analysis. (B) Northern blot analysis of the steady-state levels of
K1bAR mRNA in the control and septic rat livers. Northern
blot analysis was performed as described in Section 2 using to-
tal cellular RNA. The speci¢c cDNA probe used was a full-
length hamster K1bAR cDNA cloned into the EcoRI site of
plasmid pSP65. All K1bAR mRNA levels were normalized rela-
tive to the level of 28S rRNA to correct for the potential di¡er-
ence in the amount of RNA loaded. ES, early sepsis ; LS, late
sepsis.
Fig. 4. (A) A representative autoradiograph of nuclear run-o¡
assay. (B) Nuclear run-o¡ assay of the transcription rates of
K1bAR mRNA in the control and septic rat livers. Nuclear run-
o¡ assay was conducted as described in Section 2 using K1bAR
cDNA cloned into the EcoRI site of plasmid pSP65 and syn-
thetic 28S rRNA oligonucleotide as speci¢c probes. ES, early
sepsis; LS, late sepsis.
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and the late phases of sepsis (5.6 þ 0.24, 5.5 þ 0.25,
and 5.3 þ 0.31 h for control, early sepsis, and late
sepsis, respectively) (Fig. 5B). These data (Figs. 4
and 5) unequivocally demonstrate that the transcrip-
tion rate of K1bAR mRNA was enhanced during the
early stage, followed by attenuation during the late
stage of sepsis, without changing the rate of degra-
dation.
4. Discussion
Data presented in the current study demonstrate
that the density of K1AR (Fig. 1) and the K1AR
protein concentration (Fig. 2) were increased in par-
allel during the early phase while they were decreased
in parallel during the late phase of sepsis in the rat
liver. These results are consistent with our previously
¢ndings that in addition to the altered intracellular
translocation between the surface membrane and the
intracellular site [8], K1AR was overexpressed during
the initial stage followed by a subsequent underex-
pression in the rat liver during the progression of
sepsis. Since the activation of K1AR in the liver is
known to increase hepatic glucose output into the
circulation [6,7], an initial overexpression of K1AR
would lead to the development of the hyperglycemia
during the early phase of sepsis while the subsequent
underexpression of K1AR would result in the forma-
tion of the hypoglycemia during the late phase of
sepsis. Our ¢ndings, thus, may have a pathophysio-
logical signi¢cance in contributing to the understand-
ing of the altered glucose homeostasis during sepsis.
Recent advances in the studies of molecular biol-
ogy of K1AR have indicated that K1AR is composed
of three di¡erent genes, K1a, K1b, and K1d, with K1b
being the predominant gene expressed in the rat liver
[4,6,24]. K1bAR gene has three transcripts of 2.3, 2.7,
and 3.3 kb in length. The 3.3 kb species is preferen-
tially expressed in the liver while the 2.7 kb species is
highly expressed in the heart. The low abundance 2.3
kb species is di⁄cult to detect in the liver [25^27].
Using a speci¢c K1bAR cDNA probe for Northern
blot analysis (Fig. 3), we found that the steady-state
level of K1bAR mRNA was increased during the
early phase while it was decreased during the late
phase of sepsis. Since the increase in the K1bAR
mRNA abundance during the early phase of sepsis
paralleled with the elevations in the density and the
protein concentration of K1AR, while the decrease in
the K1bAR mRNA abundance during the late phase
of sepsis coincided with the declines in the density
and the protein concentration of K1AR, it is con-
cluded that changes in the dynamic and the protein
level of hepatic K1AR during the progression of sep-
sis were a result of the altered expression of K1bAR
gene transcript.
Regulation of gene expression is divided into three
categories: pre-transcriptional, transcriptional, and
post-transcriptional [28,29]. Pre-transcriptional
events include signal transduction, second messenger
activation, and the activation of transcriptional fac-
tors speci¢c to the regulatory region of each speci¢c
gene. Transcriptional events include the initiation of
RNA synthesis, elongation of the nascent RNA
chain, and termination of RNA synthesis. Post-tran-
scriptional events include processing of the RNA
Fig. 5. (A) A representative autoradiograph of half-life assay.
(B) Stability (half-life) assay of K1bAR gene transcripts in the
control and septic rat livers. The half-life of K1bAR gene tran-
scripts was measured as described in Section 2 using total cellu-
lar RNA prepared from liver tissue slices and the speci¢c
cDNA probe identical to that of Northern blot analysis. The
half-life of K1bAR gene transcript was calculated as time re-
quired for the 50% reduction in mRNA level. ES, early sepsis ;
LS, late sepsis.
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transcript into mRNA, translation of that mRNA
into protein, protein modi¢cation, and protein ex-
port [28^30]. The steady-state levels of mRNA meas-
ured by Northern blotting are dependent upon the
transcriptional synthesis of mRNA and its post-tran-
scriptional degradation. In the nuclear run-o¡ assay,
the isolated nuclei elongate (but not initiate) RNA
transcripts and the incorporation of a radioactive
RNA precursor is proportional to the transcriptional
activity of each gene at the time the nuclei are isolat-
ed [20]. Our ¢ndings that the rate of transcription of
K1bAR mRNA was increased during the early phase
while it was decreased during the late phase of sepsis
(Fig. 4), thus indicate that the altered expression of
K1bAR mRNA during the progression of sepsis was
regulated transcriptionally. Although the length of
the transcript’s poly(A) tail and the poly(A) bind-
ing protein have been associated with the stability of
speci¢c mRNAs, and many unstable transcripts have
one or more copies of an AU-rich motif in their 3P-
untranslated regions, none of these structural ele-
ments appear to be present in the rat K1bAR mRNA
[10,31]. Our ¢ndings that the half-life of K1bAR
mRNA remained unaltered during the early and the
late phases of sepsis (Fig. 5), thus indicate that the
post-transcriptional mechanism did not play a role
in the regulation of the altered expression of K1bAR
gene transcript during the progression of sepsis.
Structurally, the rat K1bAR gene is composed of
two exons and a single large intron. The proximal 5P-
£anking region contains three discrete transcription
start points, tsp1, tsp2, and tsp3. The K1bAR mRNAs
are transcribed from three distinct promoters, P1, P2
and P3, with direct transcription from tsp1, tsp2, and
tsp3, respectively [25^27,32]. The proximal promoter,
P1, is involved with the generation of the low abun-
dance 2.3 kb mRNA species and contains no homol-
ogies with the consensus sequences of known tran-
scription factors. The middle promoter, P2, is re-
sponsible for the generation of 2.7 kb mRNA species
and contains binding sites for several trans-acting
factors. The distal promoter, P3, is responsible for
the transcription of the 3.3 kb species and contains
cis-recognition sites for liver-speci¢c transcription
factors [25^27,32]. A variety of transcription factors
are known to a¡ect the transcription of hepatic
K1bAR gene, among which NF1 (nuclear factor 1),
HNF5 (hepatocyte nuclear factor 5), and C/EBP
(CCAAT/enhancer binding protein) are considered
the most important [26,27]. It has been reported
that in the remnant liver after partial hepatectomy,
the level of NF1 and its binding to P2 were decreased
and that the decreases were associated with the de-
clines in the rate of transcription of the K1bAR gene
and in the steady-state level of its mRNA [27]. Fur-
thermore, the down-regulation of K1bAR in the rat
liver following partial hepatectomy was found to be
associated with a marked decrease in the 2.7 kb
mRNA species [25], which was thought to be related
to the reported decrease in C/EBP expression in the
regenerating rat liver [25,33]. In light of the above, it
is conceivable that changes in the level and/or the
binding a⁄nity of various transcription factors such
as NF1, C/EBP, or HNF5 are responsiblez for the
altered expression of K1bAR mRNA gene transcripts
in the liver during the progression of sepsis. Further
investigation of the possible participation of various
transcription factors may shed light on the exact
mechanism leading to the initial overexpression and
the subsequent underexpression of K1bAR gene tran-
scripts in the liver during the progression of sepsis.
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